openPR Logo
Press release

Antimetabolite Drugs Market - Significant Growth Rate & Forecast 2017 - 2025

01-10-2018 11:18 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Antimetabolite Drugs Market - Significant Growth Rate &

Antimetabolite is a chemical that inhibits a metabolite or interfere with metabolic pathways by enzymatic reaction. Antimetabolites are purine or pyrimidine analogs and folic acids. These chemicals are characterized by low molecular weight molecules and are one of the important chemotherapeutic agents. These chemicals have a similar structure like molecules used in nucleic acid synthesis. These are used as cancer therapeutics in leukemia, ovarian, and gastrointestinal cancers. The presence of these drugs has a negative impact on cell cycles as these drugs stop the cell growth and division; hence, these drugs are primarily used as chemotherapeutics in cancers. Antimetabolites are used in different applications such as trabeculectomy and antibiotics.

The global antimetabolite drugs market is expected to expand at a significant growth rate during the forecast period. According to the World Health Organization, cancer is the leading cause of morbidity and mortality globally which impacts about 14 million people annually, resulting in the rapid increase in research activities worldwide. This is one of the major factors attributed to the growth of the global antimetabolite drugs market during the forecast period. Increasing prevalence of unhealthy lifestyles such as cigarette smoking, pipes, cigar smoking, and continuous exposure to asbestos are major factors that can cause cancer, which in turn, are projected to drive the growth of the market. Furthermore, factors such as development in the fields of drug delivery and oncology, and increased government funding and initiative to create awareness about cancer diagnosis and treatment are expected to propel the growth of the global market in the next few years. However, factors such as lack of awareness about health in many developing countries, high cost of drugs, and adverse effects of chemotherapies are projected to restrain the growth of the global antimetabolite drugs market during the forecast period.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37637

The global market for antimetabolite drugs is divided into type, application, and region. In terms of type, the global market is bifurcated into purine analogs, pyrimidine analogs, and folates. The folates segment is expected to account for a significant share of the global market since the drugs are more commonly used. In terms of application, the global market is divided into cancer therapeutics, antibiotics, and others. The cancer therapeutics segment is expected to dominate the global market during the forecast period. Factors such as high growing prevalence of cancer globally and high research activities in many regions are anticipated to fuel the segment growth.

Geographically, the global market for antimetabolite drugs is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to account for a significant share of the global market during the forecast period due to factors such as rise in incidence of cancer, prevalence of unhealthy lifestyle, and increase in government funding. Furthermore, increasing health care expenditure, advanced technology, high research activities, and rise in awareness about cancer treatment are expected to boost the market growth in the region. Europe is anticipated to hold the second highest share of the global market. Asia Pacific is expected to register the highest growth rate during the forecast period due to factors such as growing health care expenditure, rising geriatric population, surge in disposable income, prevalence of chronic diseases, growing focus of global pharmaceutical companies toward the Asia Pacific region, and rising awareness about novel drugs for cancer treatment.

Check Discount on Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=37637
Key players operating in the global antimetabolite drugs market include Teva Parenteral Medicines, Inc., Fresenius Kabi Oncology Limited, Cadila Pharmaceuticals, Celon Laboratories Pvt. Ltd, and Eli Lilly and Company.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Report Details @ https://www.transparencymarketresearch.com/antimetabolite-drugs-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antimetabolite Drugs Market - Significant Growth Rate & Forecast 2017 - 2025 here

News-ID: 893663 • Views:

More Releases from Transparency Market Research

Electric Wheelchair Market Expanding at 9.2% CAGR Through 2036 - By Control Type / By Drive Configuration / By End-use | U.S. • Germany • China • Japan
Electric Wheelchair Market Expanding at 9.2% CAGR Through 2036 - By Control Type …
The global electric wheelchair market continues to demonstrate strong and sustained growth, fueled by demographic transitions, technological innovation, and expanding healthcare access worldwide. Valued at US$ 5.8 billion in 2025, the market is projected to reach US$ 15.3 billion by 2036, expanding at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2036. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4198 This robust trajectory reflects rising
Vehicle Predictive Maintenance Market Size Forecast to USD 13.7 Billion by 2036 with a Focus on AI-Driven Fleet Optimization - Analysis by Transparency Market Research
Vehicle Predictive Maintenance Market Size Forecast to USD 13.7 Billion by 2036 …
Vehicle Predictive Maintenance Market Outlook 2036 The global vehicle predictive maintenance market was valued at USD 3 Billion in 2025 and is projected to reach USD 13.7 Billion by 2036, expanding at a robust CAGR of 14.7% from 2026 to 2036. Market growth is driven by increasing adoption of connected vehicles, rising fleet digitalization, advancements in AI-driven analytics, and growing emphasis on minimizing vehicle downtime and maintenance costs. 👉 Get your sample
Global Air Purification Systems Market to Reach USD 44.3 Billion by 2036 at 7.9% CAGR Driven by Regulatory Mandates, Smart Building Integration, and Rising Health Risks
Global Air Purification Systems Market to Reach USD 44.3 Billion by 2036 at 7.9% …
The global Air Purification Systems Market was valued at US$ 19.2 Bn in 2025 and is projected to expand to US$ 44.3 Bn by 2036, registering a compound annual growth rate (CAGR) of 7.9% from 2026 to 2036. The market's upward trajectory reflects the structural shift in indoor air quality (IAQ) management, moving from discretionary consumer spending to mission-critical infrastructure investment. With historical data available from 2021 to 2024, the industry
Polyvinylpyrrolidone (PVP) Market to Reach USD 6.2 Billion by 2036 Driven by Pharmaceutical and Cosmetic Demand
Polyvinylpyrrolidone (PVP) Market to Reach USD 6.2 Billion by 2036 Driven by Pha …
The Polyvinylpyrrolidone (PVP) Market was valued at around US$ 3.2 billion in 2025 and is projected to reach approximately US$ 6.2 billion by 2036, expanding at a steady CAGR of about 6.0% during the forecast period. This growth is primarily driven by rising demand from the pharmaceutical industry, where PVP is widely used as a tablet binder, solubilizer, and stabilizer, along with increasing consumption in cosmetics and personal care products

All 5 Releases


More Releases for Antimetabolite

United States Antimetabolite Drugs Market Strengthens Every Ounce at 3.3% CAGR - …
Leander, Texas and TOKYO, Japan - Dec. 16, 2025. According to DataM Intelligence, the United States Antimetabolite Drugs Market Size is growing from USD 4.0 billion in 2024 to USD 5.0 billion by 2031, registering a steady CAGR of 3.3% during 2025-2031. The surging incidence of cancers and autoimmune diseases, the growing adoption of combination chemotherapy regimens, and advancements in oral formulations addressing patient compliance are fueling the demand for
United States Antimetabolite Drugs Market to Reach USD 12.53 Billion by 2033, Dr …
The global Antimetabolite Drugs Market reached USD 9.38 Billion in 2024 and is projected to reach USD 12.53 Billion by 2033, growing at a CAGR of 3.3% during the forecast period 2025-2033, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Bristol-Myers Squibb received FDA approval for a novel antimetabolite combination therapy for advanced colorectal cancer. ✅ In October 2025, The National Cancer Institute launched a
Top Market Shifts Transforming the Antimetabolite Drug Market Landscape: Key Ins …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Antimetabolite Drug Market Through 2025? The market size of antimetabolite drugs has seen significant growth in the past few years. It is poised to expand from $9.31 billion in 2024 to $9.77 billion in 2025, experiencing a compound annual growth rate (CAGR)
Antimetabolite Drugs Market Explained: Key Cancer-Fighting Agents Blocking DNA S …
Antimetabolite Drugs Market reached US$ 9.38 Billion in 2024 and is expected to reach US$ 12.53 Billion by 2033, growing at a CAGR of 3.3% during the forecast period 2025-2033. Antimetabolite Drugs Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM
Antimetabolite Drugs Market Demonstrates A Spectacular Growth By 2031 | Bristol- …
WMR's latest research study on the "Antimetabolite Drugs Market Insights 2024-2031" spans over 120+ pages, offering a comprehensive analysis of business strategies adopted by key and emerging industry players. It provides insights into current market developments, landscape, technologies, drivers, opportunities, market outlook, and status. Understanding the market segments aids in recognizing the significance of various factors contributing to market growth. The report profiles top players and segments the market by Type
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol